Faramarz Mehrnejad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Faramarz Mehrnejad has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Majid Jafari
Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824
9 shared publications - Hossein Naderi-Manesh
Department of Biophysics, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran
8 shared publications Farahnoosh Doustdar
Shahid Beheshti Univ Med Sci, Fac Med, Dept Microbiol, Tehran 198396311, Iran
6 shared publicationsNader Chaparzadeh
Department of Cellular and Molecular Biology, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran
6 shared publications- Mahmoud Khadem-Maaref
Department of Physics, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran
5 shared publications Mohammad Yahyaei
Department of Animal Science, Faculty of Agriculture and Natural Science, Arak University, Arak, Iran
5 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2517
Multi-Target Computational Screening Identifies Robinin as a Potential Natural Broad-Spectrum ATP-Competitive Candidate for ABC Transporters Associated with Multidrug Resistance
Background: Several ATP-binding cassette (ABC) transporters are associated with multidrug resistance (MDR) in cancers and pathogens. Targeting their nucleotide-binding domains (NBDs), which drive ATP hydrolysis, is a promising strategy to overcome MDR. This study aimed to identify natural ATP-competitive modulators with reported anticancer and MDR-modulating activities, targeting the NBDs of the major MDR-associated transporters ABCB1, ABCC1, and ABCG2. Methods: A total of 71 natural compounds were docked with the isolated NBDs of the three transporters. The top five hit compounds were further evaluated for structural stability, hydrogen-bond networks, residue-contact frequencies, and binding affinity using GROMACS MD simulations and MM/PBSA free-energy analysis. Results: Five compounds—(–)-catechingallate, limonin, naringin, rhoifolin, and robinin—identified through molecular docking exhibit favorable docking scores for the ATP-binding pockets of all three transporters (ranging from −6.57 ± 0.21 to −8.63 ± 0.32 kcal/mol). MD simulations revealed that robinin demonstrated the greatest structural stability, sustained hydrogen-bonding networks (averaging 5.35 per frame; range 3.04–7.48), high residue-contact frequencies (up to 60 contacts per frame), and consistently low minimum distances (approximately 0.17 nm) within the ATP-binding site across all transporters. Free-energy analysis additionally indicated that all five compounds exhibited energetically favorable interactions, with robinin demonstrating the most favorable and reliable binding free energy (−24.41 to −48.0 kcal/mol). Conclusions: Our findings suggest that robinin is a promising predicted candidate that may act as an ATP-competitive modulator of MDR-associated ABC transporters. Additional experimental validation is required to confirm direct binding and therapeutic potential in overcoming drug resistance.
- 2 November 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2517
Open AccessMulti-Target Computational Screening Identifies Robinin as a Potential Natural Broad-Spectrum ATP-Competitive Candidate for ABC Transporters Associated with Multidrug Resistance
Background: Several ATP-binding cassette (ABC) transporters are associated with multidrug resistance (MDR) in cancers and pathogens. Targeting their nucleotide-binding domains (NBDs), which drive ATP hydrolysis, is a promising strategy to overcome MDR. This study aimed to identify natural ATP-competitive modulators with reported anticancer and MDR-modulating activities, targeting the NBDs of the major MDR-associated transporters ABCB1, ABCC1, and ABCG2. Methods: A total of 71 natural compounds were docked with the isolated NBDs of the three transporters. The top five hit compounds were further evaluated for structural stability, hydrogen-bond networks, residue-contact frequencies, and binding affinity using GROMACS MD simulations and MM/PBSA free-energy analysis. Results: Five compounds—(–)-catechingallate, limonin, naringin, rhoifolin, and robinin—identified through molecular docking exhibit favorable docking scores for the ATP-binding pockets of all three transporters (ranging from −6.57 ± 0.21 to −8.63 ± 0.32 kcal/mol). MD simulations revealed that robinin demonstrated the greatest structural stability, sustained hydrogen-bonding networks (averaging 5.35 per frame; range 3.04–7.48), high residue-contact frequencies (up to 60 contacts per frame), and consistently low minimum distances (approximately 0.17 nm) within the ATP-binding site across all transporters. Free-energy analysis additionally indicated that all five compounds exhibited energetically favorable interactions, with robinin demonstrating the most favorable and reliable binding free energy (−24.41 to −48.0 kcal/mol). Conclusions: Our findings suggest that robinin is a promising predicted candidate that may act as an ATP-competitive modulator of MDR-associated ABC transporters. Additional experimental validation is required to confirm direct binding and therapeutic potential in overcoming drug resistance.
- 3 August 2026
- Published by Springer Nature in Biophysical Reviews
- Vol. 18 (4) , 781-808
Protein-nanostructure interactions in drug delivery systems: insights from molecular dynamics simulations
Protein-based therapeutics have become an important part of modern medicine, offering highly specific and effective treatments for a wide range of diseases and improving patients’ quality of life compared with many conventional small-molecule drugs. Owing to their macromolecular nature, the successful administration of these agents has consistently faced significant challenges. The rapid advancement of nanotechnology in recent decades has encouraged the development of innovative and cost-effective nanostructured systems designed to improve protein stability, protection, and targeted delivery. Direct observation of underlying phenomena at the subatomic scale between nanostructures and proteins is usually not feasible in experimental setups; in this context, molecular modeling techniques such as molecular dynamics (MD) have paved the way for revealing the molecular mechanisms governing protein-nanostructure interactions and stability. In this review, we summarize recent computational studies on protein-nanostructure interactions with different classes of nanomaterials, including biocompatible polymers (chitosan, PLGA), inorganic nanoparticles (AuNPs, ZnONPs), and carbon-based materials (SWCNTs, C60). These investigations demonstrate that MD simulations can explain mechanisms of adsorption, encapsulation, conformational stability, structural change, and protein corona formation, thus supporting the rational design of improved nanocarriers. Despite the growing interest in nanomedicine, MD investigations of lipid-based nanostructures remain relatively limited, even though these systems are widely used in pharmaceutical formulations. We further discuss the important factors affecting the accuracy and predictive capability of MD simulations, including force field selection, system representation, simulation timescale, and molecular resolution. Future progress needs transferable parameters, improved pH-dependent modeling, and the integration of multiscale simulation methods to capture complex phenomena like protein corona formation.
- 3 August 2026
- Published by Springer Nature in Biophysical Reviews
- Vol. 18 (4) , 781-808
Protein-nanostructure interactions in drug delivery systems: insights from molecular dynamics simulations
Protein-based therapeutics have become an important part of modern medicine, offering highly specific and effective treatments for a wide range of diseases and improving patients’ quality of life compared with many conventional small-molecule drugs. Owing to their macromolecular nature, the successful administration of these agents has consistently faced significant challenges. The rapid advancement of nanotechnology in recent decades has encouraged the development of innovative and cost-effective nanostructured systems designed to improve protein stability, protection, and targeted delivery. Direct observation of underlying phenomena at the subatomic scale between nanostructures and proteins is usually not feasible in experimental setups; in this context, molecular modeling techniques such as molecular dynamics (MD) have paved the way for revealing the molecular mechanisms governing protein-nanostructure interactions and stability. In this review, we summarize recent computational studies on protein-nanostructure interactions with different classes of nanomaterials, including biocompatible polymers (chitosan, PLGA), inorganic nanoparticles (AuNPs, ZnONPs), and carbon-based materials (SWCNTs, C60). These investigations demonstrate that MD simulations can explain mechanisms of adsorption, encapsulation, conformational stability, structural change, and protein corona formation, thus supporting the rational design of improved nanocarriers. Despite the growing interest in nanomedicine, MD investigations of lipid-based nanostructures remain relatively limited, even though these systems are widely used in pharmaceutical formulations. We further discuss the important factors affecting the accuracy and predictive capability of MD simulations, including force field selection, system representation, simulation timescale, and molecular resolution. Future progress needs transferable parameters, improved pH-dependent modeling, and the integration of multiscale simulation methods to capture complex phenomena like protein corona formation.
- 19 February 2026
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 40 (1) , 65
Effect of emulsion-based nanosystems on the encapsulation behavior of triptorelin using molecular dynamics simulation
- 19 February 2026
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 40 (1) , 65
Effect of emulsion-based nanosystems on the encapsulation behavior of triptorelin using molecular dynamics simulation
- 9 December 2025
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 143, 109255
Investigating the pH influence on insulin fibril stability: Molecular dynamics insights
- 9 December 2025
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 143, 109255
Investigating the pH influence on insulin fibril stability: Molecular dynamics insights
- 22 August 2025
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 773, 110602
Unraveling the mechanisms of spinigerin: A promising antimicrobial peptide against antibiotic resistance through molecular dynamics simulations
- 22 August 2025
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 773, 110602
Unraveling the mechanisms of spinigerin: A promising antimicrobial peptide against antibiotic resistance through molecular dynamics simulations
- 28 November 2022
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 79
Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer
- 28 November 2022
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 79
Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer